We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




At Least Twenty Genes Regulate Cellular Cholesterol Metabolism

By LabMedica International staff writers
Posted on 16 Jul 2009
Maintaining the proper level of cholesterol is critical to avoiding vascular lipid deposits that are the prelude to heart disease. More...
To manage this task cells utilize a panel of at least 20 enzymes.

To study how cells maintain their cholesterol balance at the molecular level investigators at the University of Heidelberg (Germany) first used genome-wide gene-expression profiling of sterol-depleted cells and systematic literature queries to identify candidate genes. To further refine the list of candidate genes they developed two microscopic assays that allowed them to observe how blocking individual genes with siRNA (small interfering RNA) affected cholesterol metabolism. One assay used the cholesterol-binding dye Filipin to visualize cellular cholesterol levels, while the other employed fluorescence-labeled LDL (low density lipoprotein) to show cellular internalization.

Results published in the July 8, 2009, issue of the journal Cell Metabolism revealed that 20 genes acted as functional regulators of cellular cholesterol homeostasis. Of these, the TMEM97 gene was identified as an SREBP (sterol regulatory element binding protein) target gene that under sterol-depleted conditions localized to lysosomal compartments and bound to the LDL cholesterol transport-regulating protein Niemann-Pick C1 (NPC1).

SREBPs are transcription factors that bind to the sterol regulatory element DNA sequence TCACNCCAC. When not activated, SREBPs are attached to the nuclear envelope and endoplasmic reticulum membranes. In cells with low levels of sterols, SREBPs are cleaved to a water-soluble N-terminal domain that migrates to the nucleus. These activated SREBPs then bind to specific sterol regulatory element DNA sequences and up regulate the synthesis of enzymes involved in sterol biosynthesis. Sterols in turn inhibit the cleavage of SREBPs, and therefore synthesis of additional sterols is reduced through a negative feed back loop.

"High cholesterol in the blood is considered to be responsible for excess cardiovascular morbidity and mortality," said Dr. Heiko Runz, professor of human genetics at the University of Heidelberg. "Blood cholesterol levels are controlled by cholesterol in cells. Therefore, some of the genes identified by us as regulators of cellular cholesterol in future studies might turn out to be disease genes that contribute to hypercholesterolemia in some cases. Moreover, the strategy we used could open a new avenue to identify risk factors for cardiovascular disease."

Related Links:

University of Heidelberg




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.